316 related articles for article (PubMed ID: 23692437)
1. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
2. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
3. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
4. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
5. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
6. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
Mutch NJ; Waters EK; Morrissey JH
J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
[TBL] [Abstract][Full Text] [Related]
7. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
[TBL] [Abstract][Full Text] [Related]
8. Factor XII Contact Activation.
Naudin C; Burillo E; Blankenberg S; Butler L; Renné T
Semin Thromb Hemost; 2017 Nov; 43(8):814-826. PubMed ID: 28346966
[TBL] [Abstract][Full Text] [Related]
9. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
[TBL] [Abstract][Full Text] [Related]
10. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
13. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
14. Factor XII/XIIa inhibitors: Their discovery, development, and potential indications.
Davoine C; Bouckaert C; Fillet M; Pochet L
Eur J Med Chem; 2020 Dec; 208():112753. PubMed ID: 32883641
[TBL] [Abstract][Full Text] [Related]
15. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
[TBL] [Abstract][Full Text] [Related]
16. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.
Konings J; Govers-Riemslag JW; Philippou H; Mutch NJ; Borissoff JI; Allan P; Mohan S; Tans G; Ten Cate H; Ariëns RA
Blood; 2011 Oct; 118(14):3942-51. PubMed ID: 21828145
[TBL] [Abstract][Full Text] [Related]
17. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
Bompiani KM; Monroe DM; Church FC; Sullenger BA
J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
[TBL] [Abstract][Full Text] [Related]
18. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
19. Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin.
Sylman JL; Daalkhaijav U; Zhang Y; Gray EM; Farhang PA; Chu TT; Zilberman-Rudenko J; Puy C; Tucker EI; Smith SA; Morrissey JH; Walker TW; Nan XL; Gruber A; McCarty OJT
Ann Biomed Eng; 2017 May; 45(5):1328-1340. PubMed ID: 27933406
[TBL] [Abstract][Full Text] [Related]
20. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics.
Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T
Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
